Portfolio company Miromatrix was acquired by United Therapeutics.
Miromatrix is pioneering technology to bioengineer fully transplantable human organs, aiming to eliminate the organ transplant waitlist
Miromatrix is pioneering technology to bioengineer fully transplantable human organs, aiming to eliminate the organ transplant waitlist. Their patented perfusion decellularization and recellularization technology utilizes human cells to create new organs from a non-cellular matrix derived from pig organs.